The mechanism of action of urea on serum cholinesterase and the application of the inhibition by urea in the typing of the abnormal genes of this enzyme were investigated. Urea caused a competitive, irreversible inhibition of serum cholinesterase, which was most pronounced for the abnormal enzymes. Urea inhibition, used with dibucaine inhibition, allowed differentiation between all the known genotypes of locus El. In the differentiation of rarer genotypes, the combination of urea numbers (percentage inhibition of serum cholinesterase activity caused by urea 5 mol litre-') and dibucaine numbers was found, in certain situations, to be superior to the classical combination of fluoride and dibucaine numbers.
Acylcholine acyl-hydrolase, E.C. 3.1.1.8, also called ~seudocholinesterase or serum cholinesterase, exists as several variants. These are determined genetically by at least four allelic genes functioning at the same locus El: the normal gene, the atypical gene, the fluoride-resistant gene, and the silent gene which gives rise to 10 genotypes. These variants, some of which can cause sensitivity to suxamethonium, can be identified by means of inhibitors such as dibucaine (Kalow and Genest, 1957) , sodium fluoride (Harris and Whittaker, 1961) , sodium chloride (Whittaker, 1968) and suxamethonium (King and Grifiin, 1973) . It has been reported also that inhibition by urea could be used to detect abnormal variants (Hanel and Viby-Mogensen, 1971 ).
The purpose of this investigation was to study the mechanism of action of urea on serum cholinesterase and to illustrate its application in the typing of abnormal genotypes.
MATERIALS AND METHODS
Blood was sampled from patients and relatives registered in the Danish Cholinesterase Card Index (Viby-Mogensen and Hanel, 1977) . All investigations were performed on either fresh serum or serum which had been stored frozen at -20 "C.
Serum cholinesterase activity was determined using the technique of Kalow and Davies (1958) . In a recording spectrophotometer, at 25 "C, the change in light absorbance at 240 nrn was plotted against reaction time. Enzymatic activity was then calculated from the slope of the straight line obtained as pmole of benzoylcholine hydrolysed per minute. The activity was calculated per litre of serum (u. litre-l).
Because urea 5 mol litre-I was employed as an inhibitor for serum cholinesterase, the following modifications of the standard method were introduced. Reagents for the incubation mixture were prepared as follows: Solution 1. 24.4 mg of benzoylcholine hydrochloride was dissolved in 100.0 ml of phosphate buffer 1/15 mol litre-l, pH = 7.4 units. Solution 2. 13.20 g of urea (carbamide) was dissolved in 20.0 ml of a diluted solution 1 (1 part of solution 1 plus 19 parts of phosphate buffer 1/15 mol litre-l, pH = 7.4 units.) Solution 2 was prepared just before use, as urea does not keep well in solution. Before use, the temperature of both solutions was brought to 25 "C. Fifteen hundred microlitre of each solution plus 20 ylitre of serum were pipetted into a quartz cuvette of 1-cm light path, and measured. The result was compared with a measurement, made under identical conditions, of the same serum minus the urea.
Solutions with other inhibitors were prepared in a similar manner by replacing the urea with a suitable amount of the appropriate inhibitor.
Genetic variations of serum cholinesterase were detected by the following methods : dibucaine number (Kalow and Genest, 1957) , fluoride number (Harris and Whittaker, 1961) , chloride number (Whittaker, 1968) and suxarnethonium number (King and Griffin, 1973) . 
